{"filing":{"accession_number":"0001493152-26-031972","cik":"0001541157","ticker":"AKTX","company_name":"Akari Therapeutics Plc","form":"8-K","filing_date":"2026-07-02","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226031972/form8-k.htm"},"events":[{"id":16016,"run_id":14287,"accession_number":"0001493152-26-031972","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of Akari's Annual General Meeting held on June 30, 2026, including voting outcomes on 16 resolutions covering board re-elections, auditor appointments, executive compensation, and equity issuances. Notably, director James Neal failed to receive requisite shareholder approval and was not re-elected, triggering his departure from the board and his committee roles. This is a classic Item 5.07 shareholder vote results disclosure with material governance consequences.","company_name":"Akari Therapeutics Plc","ticker":"AKTX","filing_date":"2026-07-02","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":13963,"accession_number":"0001493152-26-031972","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of Akari's Annual General Meeting held on June 30, 2026, including voting outcomes on 16 resolutions covering board re-elections, auditor appointments, executive compensation, and equity issuances. Notably, director James Neal failed to receive requisite shareholder approval and was not re-elected, triggering his departure from the board and his committee roles. This is a classic Item 5.07 shareholder vote results disclosure with material governance consequences.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T21:26:41.044251+00:00","company_name":"Akari Therapeutics Plc","ticker":"AKTX","filing_date":"2026-07-02"}]}